For adjusted EPS, we expect to be in the range of $3.50 to $3.60, the higher end of our previous guidance.
In Q3, net sales totaled $1.4 billion, up 14% as reported, up 13% in constant dollars.
Adjusted EBITDA of $103 million decreased 5.5% in Q3, with margins at 16.9%, down 350 basis points versus last year.
Our net sales we now estimate are approximately $5.5 billion or up approximately 12% as reported growth to reflect the favorable demand environment and pricing actions.
This compares to our previous range of $5.4 billion to $5.5 billion.
On a per-share basis, adjusted earnings of $0.86 were up $0.04 compared to last year.
Adjusted earnings per diluted share in Q3 was $0.86 compared to $0.82 in Q3 2020.
And lastly, our outlook for free cash flow is expected to be in the range of $520 million to $540 million.
